Enanta Pharmaceuticals
ENTA
#8746
Rank
A$0.18 B
Marketcap
$8.75
Share price
0.72%
Change (1 day)
-56.87%
Change (1 year)

P/S ratio for Enanta Pharmaceuticals (ENTA)

P/S ratio as of April 2025 (TTM): 1.83

According to Enanta Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.09. At the end of 2024 the company had a P/S ratio of 1.91.

P/S ratio history for Enanta Pharmaceuticals from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.91-28.93%
20232.69-77.16%
202211.8-28.54%
202116.598.3%
20208.3227.67%
20196.5112.81%
20185.77-32.86%
20178.60-32.26%
201612.7169.68%
20154.71-38.15%
20147.61-92.1%
201396.3

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
6.00 228.66%๐Ÿ‡บ๐Ÿ‡ธ USA
4.18 129.08%๐Ÿ‡บ๐Ÿ‡ธ USA
11.5 527.87%๐Ÿ‡บ๐Ÿ‡ธ USA
3.27 78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
2.09 14.31%๐Ÿ‡บ๐Ÿ‡ธ USA
4.30 135.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland